| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 24,926 | 23,171 | 23,220 | 22,689 | | Cost of Revenue | 6,601 | 7,151 | 7,899 | 7,802 | | | Gross Profit |
-
| 16,020 | 15,321 | 14,887 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,194 | 16,158 | 13,367 | 14,112 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 14,756 | 5,744 | 5,328 | 19,322 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (5,882) | (3,374) | (18,547) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (10,715) | (6,792) | (3,374) | (18,547) | | Interest Expense | 1,963 | 2,013 | 2,166 | 2,702 | | Income Before Tax | (12,678) | (8,805) | (5,540) | (21,249) | | Income Tax Expense | (5,491) | (3,008) | (2,082) | (7,994) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,097) | (4,887) | (3,458) | (13,255) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,097) | (4,887) | (3,458) | (13,255) | | Preferred Stock And Other Adjustments | (650) | (650) | (708) | (165) | | | Net Income Applicable To Common Shares | ($8,747) | ($5,537) | ($4,166) | ($13,420) |
|
0.03% Nasdaq 0.00%
Income Statement
